Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 1351 AL 1365

Statin Use and Risk of Cognitive Decline in the ADNI Cohort

Kemp EC, Ebner MK, Ramanan S, Godek TA, Pugh EA, Bartlett HH, McDonald JW, Mecca MC, van Dyck CH, Mecca AP; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2020 May;28(5):507-517. doi: 10.1016/j.jagp.2019.11.003. Epub 2019 Nov 11.

Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease

Jash K, Gondaliya P, Kirave P, Kulkarni B, Sunkaria A, Kalia K.

Drug Dev Res. 2020 Apr;81(2):144-164. doi: 10.1002/ddr.21579. Epub 2019 Aug 5.

A non-invasive hidden-goal test for spatial orientation deficit detection in subjects with suspected mild cognitive impairment

Bažadona D, Fabek I, Babić Leko M, Bobić Rasonja M, Kalinić D, Bilić E, Raguž JD, Mimica N, Borovečki F, Hof PR, Šimić G.

J Neurosci Methods. 2020 Feb 15;332:108547. doi: 10.1016/j.jneumeth.2019.108547. Epub 2019 Dec 9.

Short review: Air pollution, noise and lack of greenness as risk factors for Alzheimer's disease- epidemiologic and experimental evidence

Oudin A.

Neurochem Int. 2020 Mar;134:104646. doi: 10.1016/j.neuint.2019.104646. Epub 2019 Dec 19.

Neuroimaging correlates of false memory in 'Alzheimer's disease: A preliminary systematic review

McLachlan E, Rai S, Al-Shihabi A, Huntley J, Burgess N, Howard R, Reeves S.

Psychiatry Res Neuroimaging. 2020 Feb 29;296:111021. doi: 10.1016/j.pscychresns.2019.111021. Epub 2019 Dec 9.

Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia

Orso B, Mattei C, Arnaldi D, Massa F, Serafini G, Plantone D, Doglione E, Grafman J, Nobili F, Pardini M.

Am J Geriatr Psychiatry. 2020 Jul;28(7):755-763. doi: 10.1016/j.jagp.2019.12.007. Epub 2019 Dec 17.

Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21

Cannavo C, Tosh J, Fisher EMC, Wiseman FK.

Prog Brain Res. 2020;251:181-208. doi: 10.1016/bs.pbr.2019.10.004. Epub 2019 Nov 29.

Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome

Rueda N, Flórez J, Dierssen M, Martínez-Cué C.

Prog Brain Res. 2020;251:245-268. doi: 10.1016/bs.pbr.2019.10.001. Epub 2019 Nov 1.

Beta-carotene, telomerase activity and Alzheimer's disease in old age subjects

Boccardi V, Arosio B, Cari L, Bastiani P, Scamosci M, Casati M, Ferri E, Bertagnoli L, Ciccone S, Rossi PD, Nocentini G, Mecocci P.

Eur J Nutr. 2020 Feb;59(1):119-126. doi: 10.1007/s00394-019-01892-y. Epub 2019 Jan 16.

Mechanistic complexities of bone loss in Alzheimer's disease: a review

Frame G, Bretland KA, Dengler-Crish CM.

Connect Tissue Res. 2020 Jan;61(1):4-18. doi: 10.1080/03008207.2019.1624734. Epub 2019 Jun 11.

Selenoprotein P and its potential role in Alzheimer's disease

Solovyev N.

Hormones (Athens). 2020 Mar;19(1):73-79. doi: 10.1007/s42000-019-00112-w. Epub 2019 Jun 27.

Transcranial magnetic stimulation: Emerging biomarkers and novel therapeutics in Alzheimer's disease

Koch G, Martorana A, Caltagirone C.

Neurosci Lett. 2020 Feb 6;719:134355. doi: 10.1016/j.neulet.2019.134355. Epub 2019 Jun 28.

A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment

Mavroudis IA, Petridis F, Chatzikonstantinou S, Kazis D.

Aging Clin Exp Res. 2020 Sep;32(9):1639-1646. doi: 10.1007/s40520-019-01326-z. Epub 2019 Aug 28.

Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis

Xie B, Zhou H, Liu W, Yu W, Liu Z, Jiang L, Zhang R, Cui D, Shi Z, Xu S.

Int J Neurosci. 2020 Mar;130(3):218-230. doi: 10.1080/00207454.2019.1667794. Epub 2019 Sep 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias